Bishoy Morris Faltas, Chief Research Officer at the Englander Institute for Precision Medicine and an Associate Professor of Medicine and Cell and Developmental Biology at Weill Cornell Medicine, shared a post on X:
“Bladder cancer care has undergone a sea change in recent years, creating new opportunities and new questions across the disease continuum. I am looking forward to chairing this session at AACR26: Advances in Bladder Cancer Research and Treatment: Pathways to Precision Medicine
Speakers:
- Bishoy M. Faltas, Weill Cornell Medicine
- Matthew Galsky, Mount Sinai Health System
- Ashish M. Kamat, UT MD Anderson
This will be an overview of advances in NMIBC, MIBC and metastatic disease, including perioperative strategies, patient selection, treatment sequencing, biomarkers, MRD, and mechanisms of resistance and recurrence. Looking forward to an interactive discussion on how new drugs, emerging technologies, and mechanistic insights can help move precision medicine forward in bladder cancer.
Link to add to your meeting planner.
There is so much momentum but also a lot of work that still needs to be done! Hope to see you in San Diego!”
Other articles Featuring Bishoy Morris Faltas on OncoDaily.
